Alyeska Investment Group’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Alyeska Investment Group’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-666,891	Closed	-$265K	–	575
2022 Q4	$265K	Sell	666,891 -65,702	-9%	-$43.2K	﹤0.01%	390
2022 Q3	$573K	Buy	+732,593	New	+$1.54M	0.01%	357
2021 Q2	–	Sell	-59,841	Closed	-$902K	–	916
2021 Q1	$902K	Hold	59,841	–	–	0.01%	604
2020 Q4	$1.93M	Buy	+59,841	New	+$792K	0.03%	376

Other funds holding CDAK

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Forefront Analytics West Conshohocken, Pennsylvania $110M AUM 18.54% 1-Year Est. Return

Parametrica Management Wanchai, Hong Kong $88M AUM 48.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alyeska Investment Group's CDAK Position: Q1 2023 in Review

Alyeska Investment Group sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q1 2023, closing a stake of 666,891 shares — an estimated $265K sold.

Alyeska Investment Group first reported a position in CDAK in Q4 2020 and held it in 4 quarters. The position peaked at $1.93M in Q4 2020. 27 funds tracked by Wall St. Rank hold CDAK as of Q1 2023.

Alyeska Investment Group reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Alyeska Investment Group sold 666,891 Codiak BioSciences, Inc. Common Stock shares in Q1 2023, an estimated $265K.
Alyeska Investment Group first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
Alyeska Investment Group's Codiak BioSciences, Inc. Common Stock position peaked at $1.93M in Q4 2020.
27 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q1 2023.

Based on Alyeska Investment Group's 13F filing for Q1 2023, filed 15 May 2023.